CHRW
70
13
HD
31
-3
DIS
70
10
ADT
41
4
ADI
59
2
CSCO
57
4
CVX
44
-8
BEN
38
4
CNX
49
7
CMG
54
3
CA
25
-4
BIIB
51
2
JBHT
45
2
D
41
4
BXP
44
6
NTAP
36
3
AEP
75
6
AVGO
20
17
MCD
68
5
DGX
57
6
CHRW
70
13
HD
31
-3
DIS
70
10
ADT
41
4
ADI
59
2
CSCO
57
4
CVX
44
-8
BEN
38
4
CNX
49
7
CMG
54
3
CA
25
-4
BIIB
51
2
JBHT
45
2
D
41
4
BXP
44
6
NTAP
36
3
AEP
75
6
AVGO
20
17
MCD
68
5
DGX
57
6
Financhill
Back

Altimmune Stock Predictions

AI Is Changing Marketing Forever-Invest Before the Boom

Invest Now & Secure Your Stake in RAD Intel
Sell
29

ALT
Altimmune

Last Price:
$5.56
Seasonality Move:
2.69%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Is Disrupting Marketing - Invest in the Shift

Invest Now & Be Part of RAD Intel's Breakout Year

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 2.5% based on the past 19 years of stock performance.
  • Altimmune has risen higher in 5 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 26.32%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $5.55. The Score for ALT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 2.5% based on the past 19 years of stock performance.

Altimmune Stock Rating

Sell
29
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 5 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 26.32%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
11.50
52-Week Low:
5.28

Prediction Charts

Market Cap:
427.4M
Price in USD:
5.55
Volume:
2.4M
Beta:
1.18

Technical Analysis

SMA50:
6.76
SMA100:
7.29
SMA200:
7.04
52-Wk Change:
-44.67%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 5.55 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-14 6.22 6.37 6.53 6.17
Feb-18 6.45 6.48 6.69 6.37
Feb-19 6.45 6.78 7.10 6.41
Feb-20 6.80 6.63 6.84 6.51
Feb-21 6.72 6.43 6.77 6.33
Feb-25 6.20 5.92 6.23 5.80
Feb-26 5.92 5.94 6.09 5.89
Feb-27 6.01 6.42 6.78 5.96
Feb-28 6.25 6.67 6.68 6.20
Mar-3 6.71 5.98 6.71 5.93
Mar-4 5.82 5.96 6.07 5.50
Mar-5 5.94 5.71 6.09 5.71
Mar-6 5.58 5.57 5.66 5.41
Mar-7 5.53 5.55 5.64 5.46

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.16 per share, and a decrease next year of $0.46 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.